Serotonin-Dopamine Antagonists in the Treatment of Stuttering

[ Contents | Search | Next | Previous | Up ]


Re: Nueroimaging and pharmacological research

From: Nathan Lavid, M.D.
Date: 20 Oct 2005
Time: 01:31:00 -0500
Remote Name: 71.107.205.117

Comments

Hello Liz, From a historical perspective, the genetic, neuroimaging, and pharmacologic studies are very significant; as they have solidified the notion that stuttering is a brain-based phenomenon that has a genetic component. Up until the late-nineteenth century, anatomical disruptions were thought to be the cause of stuttering, which led to hurtful treatments. Psychological causes were at the forefront of thought for the beginning to of the twentieth century, and this also led to ineffective treatments. While neuroscience research has not revealed the etiology of stuttering, it allows a framework where observations can be evaluated objectively. PubMed, available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi is where you can find applications of the scientific method to stuttering and read abstracts of these studies. Also, the Biology Journal at the Public Library of Science has a good review article on stuttering called “What causes stuttering,” which is located at http://biology.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pbio.0020046. Best of luck with your studies.


Last changed: 10/24/05